Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,698 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Drug tolerance in Mycobacterium tuberculosis.
Wallis RS, Patil S, Cheon SH, Edmonds K, Phillips M, Perkins MD, Joloba M, Namale A, Johnson JL, Teixeira L, Dietze R, Siddiqi S, Mugerwa RD, Eisenach K, Ellner JJ. Wallis RS, et al. Among authors: johnson jl. Antimicrob Agents Chemother. 1999 Nov;43(11):2600-6. doi: 10.1128/AAC.43.11.2600. Antimicrob Agents Chemother. 1999. PMID: 10543735 Free PMC article. Clinical Trial.
Pulmonary tuberculosis.
Hirsch CS, Johnson JL, Ellner JJ. Hirsch CS, et al. Among authors: johnson jl. Curr Opin Pulm Med. 1999 May;5(3):143-50. doi: 10.1097/00063198-199905000-00004. Curr Opin Pulm Med. 1999. PMID: 10228738 Review.
Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.
Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, Mugerwa RD, Ellner JJ. Johnson JL, et al. J Infect Dis. 2000 Apr;181(4):1304-12. doi: 10.1086/315393. Epub 2000 Apr 7. J Infect Dis. 2000. PMID: 10753731 Clinical Trial.
Predicting the outcome of therapy for pulmonary tuberculosis.
Wallis RS, Perkins MD, Phillips M, Joloba M, Namale A, Johnson JL, Whalen CC, Teixeira L, Demchuk B, Dietze R, Mugerwa RD, Eisenach K, Ellner JJ. Wallis RS, et al. Among authors: johnson jl. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1076-80. doi: 10.1164/ajrccm.161.4.9903087. Am J Respir Crit Care Med. 2000. PMID: 10764293 Free PMC article. Clinical Trial.
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trials.
Wallis RS, Phillips M, Johnson JL, Teixeira L, Rocha LM, Maciel E, Rose L, Wells C, Palaci M, Dietze R, Eisenach K, Ellner JJ. Wallis RS, et al. Among authors: johnson jl. Antimicrob Agents Chemother. 2001 Apr;45(4):1302-4. doi: 10.1128/AAC.45.4.1302-1304.2001. Antimicrob Agents Chemother. 2001. PMID: 11257053 Free PMC article. Clinical Trial.
Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis.
Dietze R, Teixeira L, Rocha LM, Palaci M, Johnson JL, Wells C, Rose L, Eisenach K, Ellner JJ. Dietze R, et al. Among authors: johnson jl. Antimicrob Agents Chemother. 2001 Jul;45(7):1972-6. doi: 10.1128/AAC.45.7.1972-1976.2001. Antimicrob Agents Chemother. 2001. PMID: 11408210 Free PMC article. Clinical Trial.
1,698 results